Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns: Original Article

Neuropathology

Volumn 29, Issue 5, 2009, Pages 536-542

  Minaki, Haruhiko ^a   Sasaki, Kensuke ^a   Honda, Hiroyuki ^a   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Centrifugation; Creutzfeldt Jakob disease; Gel filtration chromatography; Oligomers; Prion proteins

Indexed keywords

OLIGOMER; PRION PROTEIN; PROTEINASE K;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GEL FILTRATION; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN POLYMERIZATION;

AGED; AMYLOID; AMYOTROPHIC LATERAL SCLEROSIS; BLOTTING, WESTERN; BRAIN; CHROMATOGRAPHY, GEL; CREUTZFELDT-JAKOB SYNDROME; DEPRESSIVE DISORDER; FEMALE; GLIOSIS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; ORGAN SIZE; PRIONS; PROTEIN MULTIMERIZATION; PRPC PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 68849126894     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01007.x     Document Type: Article

References (18)

1. Creutzfeldt HG. On a particular focal disease of the central nervous system (preliminary communication), 1920. Alzheimer Dis Assoc Disord 1989 3 : 3 25.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998 95 : 13363 13383.
3. Thackray AM, Hopkins L, Bujdoso R. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J 2007 401 : 475 483.
4. Sc molecules with different conformations. Nat Med 1998 4 : 1157 1165.
5. Sc conformers induced by a synthetic peptide and several prion strains. J Virol 2004 78 : 2088 2099.
6. Safar JG, Geschwind MD, Deering C et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005 102 : 3501 3506.
7. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003 26 : 267 298.
8. Silveira JR, Raymond GJ, Hughson AG et al. The most infectious prion protein particles. Nature 2005 437 : 257 261.
9. Yuan J, Xiao X, McGeehan J et al. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem 2006 281 : 34848 34858.
10. Pan T, Wong P, Chang B et al. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J Virol 2005 79 : 934 943.
11. Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 2003 37 : 583 595.
12. Singer SJ, Dewji NN. Evidence that Perutz's double-β-stranded subunit structure for β-amyloids also applies to their channel-forming structures in membranes. Proc Natl Acad Sci USA 2006 103 : 1546 1550.
13. Lue LF, Kuo YM, Roher AE et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999 155 : 853 862.
14. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002 30 : 552 557.
15. Dahlgren KN, Manelli AM, Stine WB et al. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 2002 277 : 32046 32053.
16. Kayed R, Head E, Thompson JL et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003 300 : 486 489.
17. Lambert MP, Barlow AK, Chromy BA et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998 95 : 6448 6453.
18. Sc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 2004 279 : 16797 16804.